Table_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_15_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_5_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_7_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_8_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_11_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_9_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_6_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Table_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Table_2_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data_Sheet_13_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Table_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

“…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”

Data Sheet 1_Development of an LC-MS/MS method for astaxanthin quantification in shrimp tissues and its application to detect astaxanthin variations during ovary development stages... by Shuo Diao (1967698)

“…However, a significant redistribution of astaxanthin was observed during the post-developmental stage, characterized by a substantial decrease to 5.74 μg/g in the hepatopancreas, concomitant with an increase to 7.47 μg/g in ovarian tissue.…”

feature parameters by CHIN-CHENG CHU (20718575)

“…<p dir="ltr">We evaluated seven eye‐movement features before and after fatigue using paired t‐tests on mean ± SD values. Sample Entropy on the X-axis decreased from 0.095 ± 0.054 to 0.080 ± 0.048 (p = 0.025) and on the Y-axis from 0.106 ± 0.046 to 0.090 ± 0.043 (p = 0.025), whereas Approximate Entropy and Cross Entropy showed no significant change. …”

Supplemental Tables S1-S5 by Carolyn Morris (21298187)

“…LFD and HFD mice lost an average of 11% and 27% of their body weight, respectively. LFD mice had a 33% decrease in CCL20 in lung tissue and a 55% decrease in neutrophils in BALF. …”

Supplemental Figs. S1-S7 by Carolyn Morris (21298187)

“…LFD and HFD mice lost an average of 11% and 27% of their body weight, respectively. LFD mice had a 33% decrease in CCL20 in lung tissue and a 55% decrease in neutrophils in BALF. …”

Data Sheet 1_Qifuyin alleviates anxiety and depression in 3×Tg-AD mice by modulating neuroendocrine function.zip by Tianhao Yu (8120651)

“…In the QFY-treated group, plasma CORT levels were significantly decreased, whereas FSH and LH levels were significantly increased. …”